National Research Corp (NRC) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.513x

Based on the latest financial reports, National Research Corp (NRC) has a cash flow conversion efficiency ratio of 0.513x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($7.18 Million) by net assets ($13.99 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

National Research Corp - Cash Flow Conversion Efficiency Trend (1996–2025)

This chart illustrates how National Research Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read National Research Corp balance sheet liabilities for a breakdown of total debt and financial obligations.

National Research Corp Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of National Research Corp ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
The Star Entertainment Group Limited
F:EE9
-0.069x
Kopin Corporation
NASDAQ:KOPN
-0.005x
Ashiana Housing Limited
NSE:ASHIANA
0.120x
Huitong Construction Group Co.Ltd.
SHG:603176
N/A
Eugene Inv&Sec
KO:001200
0.184x
Banyan Gold Corp
V:BYN
0.025x
HD Renewable Energy Co. Ltd.
TW:6873
0.070x
ZKH Group Limited
NYSE:ZKH
0.078x

Annual Cash Flow Conversion Efficiency for National Research Corp (1996–2025)

The table below shows the annual cash flow conversion efficiency of National Research Corp from 1996 to 2025. For the full company profile with market capitalisation and key ratios, see National Research Corp stock valuation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 $13.99 Million $26.45 Million 1.891x +70.82%
2024-12-31 $31.28 Million $34.62 Million 1.107x +42.16%
2023-12-31 $48.95 Million $38.11 Million 0.779x +54.64%
2022-12-31 $72.03 Million $36.27 Million 0.503x -7.30%
2021-12-31 $85.34 Million $46.34 Million 0.543x -14.05%
2020-12-31 $64.31 Million $40.64 Million 0.632x -49.21%
2019-12-31 $32.89 Million $40.92 Million 1.244x -40.43%
2018-12-31 $19.08 Million $39.85 Million 2.088x +569.32%
2017-12-31 $90.04 Million $28.09 Million 0.312x -3.76%
2016-12-31 $82.81 Million $26.84 Million 0.324x +9.93%
2015-12-31 $74.22 Million $21.89 Million 0.295x -1.23%
2014-12-31 $87.75 Million $26.20 Million 0.299x +10.91%
2013-12-31 $71.75 Million $19.32 Million 0.269x -20.17%
2012-12-31 $56.74 Million $19.13 Million 0.337x +1.36%
2011-12-31 $55.55 Million $18.48 Million 0.333x +10.68%
2010-12-31 $48.58 Million $14.60 Million 0.301x -2.85%
2009-12-31 $44.17 Million $13.67 Million 0.309x -21.31%
2008-12-31 $38.60 Million $15.18 Million 0.393x +14.14%
2007-12-31 $42.29 Million $14.57 Million 0.344x +85.83%
2006-12-31 $36.75 Million $6.81 Million 0.185x -26.21%
2005-12-31 $32.59 Million $8.19 Million 0.251x +12.54%
2004-12-31 $35.02 Million $7.82 Million 0.223x -12.43%
2003-12-31 $32.42 Million $8.27 Million 0.255x +66.71%
2002-12-31 $28.02 Million $4.28 Million 0.153x +15.95%
2001-12-31 $23.35 Million $3.08 Million 0.132x +39.36%
2000-12-31 $21.38 Million $2.02 Million 0.095x -49.71%
1999-12-31 $18.60 Million $3.50 Million 0.188x -18.15%
1998-12-31 $17.40 Million $4.00 Million 0.230x +177.39%
1997-12-31 $18.10 Million $1.50 Million 0.083x -97.24%
1996-12-31 $2.10 Million $6.30 Million 3.000x --

About National Research Corp

NASDAQ:NRC USA Health Information Services
Market Cap
$430.59 Million
Market Cap Rank
#13809 Global
#3117 in USA
Share Price
$18.93
Change (1 day)
+1.39%
52-Week Range
$11.42 - $22.48
All Time High
$64.76
About

National Research Corporation provides analytics and insights to measure and improve patient and employee experience for healthcare organizations in the United States. The company offers market experience solutions, a subscription-based services for improved tracking of awareness, perception, and consistency of healthcare brands; assessment of differentiators; and segmentation tools to evaluate t… Read more